Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Wilson Bautista-Molano; Daniel G. Fernández-Ávila; María Lorena Brance; María Gabriela Ávila Pedretti; Ruben Burgos-Vargas; Inés Corbacho; Vanesa Laura Cosentino; José Francisco Díaz Coto; Enrique Giraldo Ho; Gustavo Gomes Resende; Luis Arturo Gutiérrez; Marwin Gutiérrez; Sebastián Eduardo Ibáñez Vodnizza; Edwin Jáuregui; Vanessa Ocampo; Daniel Ruben Palleiro Rivero; Penélope Esther Palominos; Cesar Pacheco Tena; Guillermo Andrés Quiceno; Lina María Saldarriaga-Rivera; Fernando Andrés Sommerfleck; Annelise Goecke Sariego; Claudia Vera Barrezueta; Luis Enrique Vega Espinoza; Oscar Vega Hinojosa; Gustavo Citera; Carlos Lozada; Percival D. Sampaio-Barros; Emilce Schneeberger; Enrique R. Soriano

doi:10.1038/s41584-023-01034-z

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Wilson Bautista-Molano, Daniel G. Fernández-Ávila, María Lorena Brance, María Gabriela Ávila Pedretti, Ruben Burgos-Vargas, Inés Corbacho, Vanesa Laura Cosentino, José Francisco Díaz Coto, Enrique Giraldo Ho, Gustavo Gomes Resende, Luis Arturo Gutiérrez, Marwin Gutiérrez, Sebastián Eduardo Ibáñez Vodnizza, Edwin Jáuregui, Vanessa Ocampo, Daniel Ruben Palleiro Rivero, Penélope Esther Palominos, Cesar Pacheco Tena, Guillermo Andrés Quiceno, Lina María Saldarriaga-RiveraFernando Andrés Sommerfleck, Annelise Goecke Sariego, Claudia Vera Barrezueta, Luis Enrique Vega Espinoza, Oscar Vega Hinojosa, Gustavo Citera, Carlos Lozada, Percival D. Sampaio-Barros, Emilce Schneeberger, Enrique R. Soriano

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.

Original language	English (US)
Pages (from-to)	724-737
Number of pages	14
Journal	Nature Reviews Rheumatology
Volume	19
Issue number	11
DOIs	https://doi.org/10.1038/s41584-023-01034-z
State	Published - Nov 2023
Externally published	Yes

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/s41584-023-01034-z

Cite this

Bautista-Molano, W., Fernández-Ávila, D. G., Brance, M. L., Ávila Pedretti, M. G., Burgos-Vargas, R., Corbacho, I., Cosentino, V. L., Díaz Coto, J. F., Giraldo Ho, E., Gomes Resende, G., Gutiérrez, L. A., Gutiérrez, M., Ibáñez Vodnizza, S. E., Jáuregui, E., Ocampo, V., Palleiro Rivero, D. R., Palominos, P. E., Pacheco Tena, C., Quiceno, G. A., ... Soriano, E. R. (2023). Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nature Reviews Rheumatology, 19(11), 724-737. https://doi.org/10.1038/s41584-023-01034-z

Bautista-Molano, W, Fernández-Ávila, DG, Brance, ML, Ávila Pedretti, MG, Burgos-Vargas, R, Corbacho, I, Cosentino, VL, Díaz Coto, JF, Giraldo Ho, E, Gomes Resende, G, Gutiérrez, LA, Gutiérrez, M, Ibáñez Vodnizza, SE, Jáuregui, E, Ocampo, V, Palleiro Rivero, DR, Palominos, PE, Pacheco Tena, C, Quiceno, GA, Saldarriaga-Rivera, LM, Sommerfleck, FA, Goecke Sariego, A, Vera Barrezueta, C, Vega Espinoza, LE, Vega Hinojosa, O, Citera, G, Lozada, C, Sampaio-Barros, PD, Schneeberger, E & Soriano, ER 2023, 'Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis', Nature Reviews Rheumatology, vol. 19, no. 11, pp. 724-737. https://doi.org/10.1038/s41584-023-01034-z

@article{b7199e8cb5c84760bcbb949793ba9d47,

title = "Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis",

abstract = "Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.",

author = "Wilson Bautista-Molano and Fern{\'a}ndez-{\'A}vila, {Daniel G.} and Brance, {Mar{\'i}a Lorena} and {{\'A}vila Pedretti}, {Mar{\'i}a Gabriela} and Ruben Burgos-Vargas and In{\'e}s Corbacho and Cosentino, {Vanesa Laura} and {D{\'i}az Coto}, {Jos{\'e} Francisco} and {Giraldo Ho}, Enrique and {Gomes Resende}, Gustavo and Guti{\'e}rrez, {Luis Arturo} and Marwin Guti{\'e}rrez and {Ib{\'a}{\~n}ez Vodnizza}, {Sebasti{\'a}n Eduardo} and Edwin J{\'a}uregui and Vanessa Ocampo and {Palleiro Rivero}, {Daniel Ruben} and Palominos, {Pen{\'e}lope Esther} and {Pacheco Tena}, Cesar and Quiceno, {Guillermo Andr{\'e}s} and Saldarriaga-Rivera, {Lina Mar{\'i}a} and Sommerfleck, {Fernando Andr{\'e}s} and {Goecke Sariego}, Annelise and {Vera Barrezueta}, Claudia and {Vega Espinoza}, {Luis Enrique} and {Vega Hinojosa}, Oscar and Gustavo Citera and Carlos Lozada and Sampaio-Barros, {Percival D.} and Emilce Schneeberger and Soriano, {Enrique R.}",

note = "Publisher Copyright: {\textcopyright} 2023, Springer Nature Limited.",

year = "2023",

month = nov,

doi = "10.1038/s41584-023-01034-z",

language = "English (US)",

volume = "19",

pages = "724--737",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

AU - Bautista-Molano, Wilson

AU - Fernández-Ávila, Daniel G.

AU - Brance, María Lorena

AU - Ávila Pedretti, María Gabriela

AU - Burgos-Vargas, Ruben

AU - Corbacho, Inés

AU - Cosentino, Vanesa Laura

AU - Díaz Coto, José Francisco

AU - Giraldo Ho, Enrique

AU - Gomes Resende, Gustavo

AU - Gutiérrez, Luis Arturo

AU - Gutiérrez, Marwin

AU - Ibáñez Vodnizza, Sebastián Eduardo

AU - Jáuregui, Edwin

AU - Ocampo, Vanessa

AU - Palleiro Rivero, Daniel Ruben

AU - Palominos, Penélope Esther

AU - Pacheco Tena, Cesar

AU - Quiceno, Guillermo Andrés

AU - Saldarriaga-Rivera, Lina María

AU - Sommerfleck, Fernando Andrés

AU - Goecke Sariego, Annelise

AU - Vera Barrezueta, Claudia

AU - Vega Espinoza, Luis Enrique

AU - Vega Hinojosa, Oscar

AU - Citera, Gustavo

AU - Lozada, Carlos

AU - Sampaio-Barros, Percival D.

AU - Schneeberger, Emilce

AU - Soriano, Enrique R.

PY - 2023/11

Y1 - 2023/11

N2 - Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.

AB - Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.

UR - http://www.scopus.com/inward/record.url?scp=85173782320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85173782320&partnerID=8YFLogxK

U2 - 10.1038/s41584-023-01034-z

DO - 10.1038/s41584-023-01034-z

M3 - Article

C2 - 37803079

AN - SCOPUS:85173782320

SN - 1759-4790

VL - 19

SP - 724

EP - 737

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 11

ER -

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this